---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-22-001566"
form_type: "8-K"
ticker: "PBSV"
cik: "0001304161"
company_name: "Pharma-Bio Serv, Inc."
filed_at: "2022-02-14T23:59:59+00:00"
generated_at: "2026-06-27T08:19:22.536354+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pharma-Bio Serv revenues fall to $20.1M, posts $2.1M net loss; declares $0.075 special dividend

## Summary
- FY 2021 revenue $20.1M, down ~$1.4M YoY; net loss $2.1M vs. prior-year net income of $2.0M.
- Net loss driven by $5.2M customer account receivable provision, partially offset by $1.9M PPP loan forgiveness.
- Adjusted net income $1.2M, down ~$0.8M YoY; excludes the receivable provision and PPP forgiveness.
- Board declares special dividend of $0.075/share, payable March 15, 2022 to holders of record Feb 25, 2022.
- Management focusing on U.S. and European markets and value-added M&A for non-organic growth.

## SEC filing metadata
- accession: 0001654954-22-001566
- form_type: 8-K
- ticker: PBSV
- cik: 0001304161
- company_name: Pharma-Bio Serv, Inc.
- filed_at: 2022-02-14T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1304161/000165495422001566/0001654954-22-001566-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1304161/000165495422001566/pbsv_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-22-001566
- JSON: https://secwatch.observer/filing/0001654954-22-001566.json
- Plain text: https://secwatch.observer/filing/0001654954-22-001566.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.